The Daily Rounds: Longevity & Health Care Brief | June 1, 2026
|

The Daily Rounds: Longevity & Health Care Brief | June 1, 2026

🧠 Alzheimer's Inflammation Switch Identified — Scripps Research maps the exact cysteine 148 site on the STING protein where S-nitrosylation triggers neuroinflammation, revealing a concrete small-molecule drug target. 🧠 Nasal Spray Reverses Brain Aging — Texas A&M's neural stem cell-derived particles reduce neuroinflammation and restore memory in aged mice for months after just two doses. ❤️ Ozempic Works Powerfully in Adults Over 65 — A new analysis confirms 15 percent-plus body weight loss and strong cardiovascular gains in older adults, reshaping GLP-1 prescribing for elderly patients. 🦠 Gut Bacteria Inject Proteins Into Human Immune Cells — Common gut microbes use type III secretion systems to directly modulate host immunity, overturning a foundational assumption in microbiome science. 😴 Sleep Regularity Trumps Sleep Duration — Actigraphy data spanning 6.8 years links irregular sleep timing to over 20 percent of the risk burden for 92 distinct diseases.

A runner demonstrating cardiorespiratory fitness, the strongest predictor of longevity according to research spanning 3.8 million people
| | |

The VO2 Max Verdict: Why Cardiorespiratory Fitness Is the Single Strongest Predictor of How Long You Will Live

A 122,000-person Cleveland Clinic study found that low cardiorespiratory fitness carries a greater mortality risk than smoking, diabetes, or coronary artery disease, with no upper limit of benefit. Inside the…

Pancreatic cancer clinical trial research 2026 | Healthcare Discovery
| | |

ASCO 2026’s Most Consequential Lung Cancer Result: Ivonescimab Cuts Death Risk by 34% in Squamous NSCLC

At ASCO 2026’s plenary session, ivonescimab, a first-in-class bispecific antibody targeting PD-1 and VEGF, cut the risk of death by 34% in advanced squamous NSCLC, becoming the first drug to…

The Daily Rounds: Longevity & Health Care Brief | May 31, 2026
|

The Daily Rounds: Longevity & Health Care Brief | May 31, 2026

🧠 Long COVID Inflammation Theory Overturned — Brain imaging finds no widespread neuroinflammation in long COVID; emotional regulation regions are overactive instead, fundamentally redirecting treatment strategy. ❤️ Inflammation Is Heart Disease's Hidden Engine — Scientific American's May cover story highlights colchicine cutting cardiac events by 31 percent in trials, shifting cardiology toward anti-inflammatory protocols. 🧠 GPNMB Protein Drives Parkinson's Spread — A Neuron study maps a self-reinforcing alpha-synuclein propagation loop and a monoclonal antibody strategy that can interrupt it. 💪 Strength Decline Starts at 35 — A 47-year Swedish study confirms muscle loss begins earlier than guidelines acknowledge, but exercise started later in life still meaningfully extends healthspan. 🔬 Senolytics Reduce Biological Age in Blood — Senolytic compounds produce measurable reductions in epigenetic age estimates, directly linking zombie-cell clearance to molecular rejuvenation signatures.

Healthcare Discovery Stanford fermented foods study showing gut microbiome diversity and lower inflammation
| | |

The 30 Plants a Week Rule: How Microbiome Diversity Became 2026’s Most Practical Nutrition Target

A quiet conclusion has emerged from microbiome science: variety, not any single superfood, predicts a resilient gut and lower systemic inflammation. Inside the American Gut Project finding that launched the…

A clinician and care coordinator reviewing a digital prior authorization workflow in a modern clinic
| |

The Prior Authorization Trap: Why Healthcare AI’s Next Delivery Test Is Getting Care Approved

Prior authorization is one of healthcare’s hidden delivery gates. In 2026, CMS rules, Medicare Advantage data, KFF polling, AMA survey findings, and insurer AI adoption are converging on a sharper…

Healthcare Discovery MechanoAge breast cancer AI mechanical age risk showing cells measured in a microfluidic diagnostic platform
| | |

First-in-Class Bispecific ADC Rewrites the Rules for Triple-Negative Breast Cancer at ASCO 2026

At ASCO 2026, izalontamab brengitecan became the first bispecific antibody-drug conjugate to improve both progression-free and overall survival in triple-negative breast cancer. Inside the EGFRxHER3 mechanism, the Phase 3 trial…

The Daily Rounds: Longevity & Health Care Brief | May 30, 2026
|

The Daily Rounds: Longevity & Health Care Brief | May 30, 2026

🧠 Ribosome Failure Drives Brain Aging: Stanford's killifish research reveals that jamming of protein-building cellular machinery may be a primary cause of age-related cognitive decline, opening a new therapeutic target class for neuroprotection. 🦠 Young Gut Bacteria Reverses Liver Aging: DDW 2026 research showed transplanting youthful microbiota into aging mice dramatically reduced liver damage and cancer risk via the gut-liver axis, accelerating the case for human trials. ❤️ CKD Reaches 800 Million People Worldwide: Chronic kidney disease is now among the world's top killers, with most cases undiagnosed until irreversible damage has occurred, demanding universal early screening. 🤖 Pfizer AI Screens Millions of Drug Candidates in 30 Days: AI-powered molecular scanning is eliminating years from early drug discovery timelines, marking a permanent structural shift in pharmaceutical R&D. 😴 Irregular Bedtime Tied to 172 Diseases: A massive sleep study found that circadian misalignment, not just short sleep, is independently associated with scores of serious diseases, reinforcing sleep consistency as a longevity lever accessible to everyone.